MEKはタンパク質の安定性を保ち,HSF1経由で腫瘍抑制性アミロジネシスを抑制します
Zijian Tang1, Siyuan Dai2, Yishu He2
1The Jackson Laboratory, 600 Main Street, Bar Harbor, ME 04609, USA; Graduate Programs, Department of Molecular and Biomedical Sciences, The University of Maine, 5735 Hitchner Hall, Orono, ME 04469, USA.
Cell
|February 14, 2015
まとめ
RAS/MAPキナーゼ経路は,RAS/MAPキナーゼ経路が,RAS/MAPキナーゼ経路は,RAS/MAPキナーゼ経路は,RAS/MAPキナーゼ経路は,RAS/MAPキナーゼ経路は,RAS/MAPキナーゼ経路は,RAS/MAPキナーゼ経路は,RAS/MAPキナーゼ経路は,RAS/MAPキナーゼ経路は,
科学分野:
- 細胞生物学 細胞生物学
- 腫瘍学 腫瘍学
- プロテオスタシス プロテオスタシス
背景:
- RAS/MAPキナーゼ経路は,細胞シグナル伝達において極めて重要です.
- ERKは以前は唯一のMEK基材と考えられていた.
- タンパク質毒性ストレス反応の調節におけるMEKの役割は不明でした.
研究 の 目的:
- 新しいMEK基板を特定するために.
- 癌におけるMEK-HSF1信号伝達の役割を調査する.
- 腫瘍のプロテオスタシスを標的とする治療戦略を探求する.
主な方法:
- MEK-HSF1の相互作用と調節を調査した.
- MEK阻害による腫瘍細胞のタンパク質変化を分析した.
- アミロイドゲネシスの腫瘍成長に対するインパクトを in vivo で評価した.
主要な成果:
- HSF1は,新しいMEK基板として特定されました.
- 腫瘍細胞におけるMEKの阻害は,タンパク質の混沌とアミロイドゲネシスを引き起こします.
- 腫瘍細胞は,プロテオミクストラブレーションに対する感受性が高くなります.
- アミロイドゲネシスは,腫瘍抑制効果を示し,メラノーマの成長を抑制します.
結論:
- 腫瘍性RAS-MEKシグナリングはプロテオスタシスを維持し,アミロイドゲネシスを抑制する.
- タンパク質の不安定性は,悪性状態に固有のものです.
- アミロジネシスを誘発するために腫瘍のプロテオスタシスをターゲットにすることは,潜在的な抗癌戦略です.
さらに関連する動画
06:41Quantitative Analysis of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Stabilization in a Neural Model of Alzheimer's Disease (AD)
Published on: January 10, 2025
1.3K
10:50Molecular Modulation by Lentivirus-Delivered Specific shRNAs in Endoplasmic Reticulum Stressed Neurons
Published on: April 24, 2021
1.4K
関連する概念動画
02:23Abnormal Proliferation
5.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.5K
01:31Regulation of the Unfolded Protein Response
3.3K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
3.3K
02:04Covalently Linked Protein Regulators
10.0K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
10.0K
01:23Regulation of Expression at Multiple Steps
1.6K
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
1.6K
01:13The Proteasome
2.0K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
2.0K
02:18The Proteasome
10.7K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.7K